Clinical Presentations and Phenotypic Spectrum of Multiple Sclerosis at a University Hospital in Saudi Arabia

다국어 초록 (Multilingual Abstract)

Background and Purpose The objective of this study was to determine the frequencies of different clinical presentations and the phenotypic spectrum of multiple sclerosis (MS).
Methods This cross-sectional study was performed in the Neurology Department of King Fahd Hospital of University Alkhobar in the Kingdom of Saudi Arabia (KSA). Data of 190 MS patients who fulfilled the McDonald criteria were retrieved from medical records and analyzed.
Results The age at disease onset was 26.27±8.2 years (mean±SD) and disease duration was 6.38±5.10 years. The male-to-female ratio was 1:1.6. Optic neuritis and myelitis were the most-frequent first clinical presentations. Sensory (73.1%), motor (61%), and visual (58.4%) symptoms were the most-frequent established clinical symptoms. Relapsing-remitting multiple sclerosis (RRMS) was present in 75% of the cases. Supratentorial T2-weighted white-matter lesions and deep-gray-matter or juxtacortical lesions were the most-frequent magnetic resonance imaging (MRI) lesions, comprising 28% and 23.7% of all MRI lesions observed in 93.6% and 79.4% of the cases, respectively. The scores on the Expanded Disability Status Scale were within the range of 1.0–5.5 in 82.1% of the patients. There were 145 (76.3%) patients taking interferon β therapy.
Conclusions MS presenting in the hospital setting is more common in KSA than reported previously, and the number of diagnosed cases in increasing. It is therefore an emerging and disabling neurological illness in KSA with clinical characteristics not dissimilar to those in other middle eastern countries. A decrease in the frequency of patients with secondary progressive multiple sclerosis (SPMS) indicates either that more new cases of RRMS are being diagnosed or that adequate treatments of RRMS are preventing the evolution to SPMS. Further larger and populationwide epidemiological and clinical studies with the long-term follow-up of MS patients are required to better assess the clinical spectrum of MS in KSA.

참고문헌 (Reference)

1 Naeem Z, "Vitamin D deficiency- an ignored epidemic" 4 : V-VI, 2010

2 Pugliatti M, "The worldwide prevalence of multiple sclerosis" 104 : 182-191, 2002

3 Ontaneda D, "Progressive multiple sclerosis" 28 : 237-243, 2015

4 Rice CM, "Primary progressive multiple sclerosis: progress and challenges" 84 : 1100-1106, 2013

5 Deleu D, "Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar" 19 : 816-819, 2013

6 Inshasi J, "Prevalence of multiple sclerosis in Dubai, United Arab Emirates" 121 : 393-398, 2011

7 Daif AK, "Pattern of presentation of multiple sclerosis in Saudi Arabia: analysis based on clinical and paraclinical features" 39 : 182-186, 1998

8 Akhtar N, "Newly diagnosed multiple sclerosis in state of Qatar" 115 : 1333-1337, 2013

9 Lublin FD, "New multiple sclerosis phenotypic classification" 72 (72): 1-5, 2014

10 Weinshenker BG, "Natural history of multiple sclerosis" 36 (36): S6-S11, 1994

11 Kalanie H, "Multiple sclerosis: report on 200 cases from Iran" 9 : 36-38, 2003

12 Milo R, "Multiple sclerosis: geoepidemiology, genetics and the environment" 9 : A387-A394, 2010

13 Bohlega S, "Multiple sclerosis in the Arabian Gulf countries: a consensus statement" 260 : 2959-2963, 2013

14 Idris MN, "Multiple sclerosis in Sudan: a prospective study of clinical presentation and outcome" 15 : 1537-1538, 2009

15 Yaqub BA, "Multiple sclerosis in Saudi Arabia" 38 : 621-623, 1988

16 Viswanathan S, "Multiple sclerosis in Malaysia: demographics, clinical features, and neuroimaging characteristics" 2013 : 614716-, 2013

17 El-Salem K, "Multiple sclerosis in Jordan: a clinical and epidemiological study" 253 : 1210-1216, 2006

18 Etemadifar M, "Multiple sclerosis in Isfahan, Iran: an update" 20 : 1145-1147, 2014

19 Montalban X, "MRI criteria for MS in patients with clinically isolated syndromes" 74 : 427-434, 2010

20 Eriksson M, "Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis" 9 : 260-274, 2003

21 Alroughani R, "Increasing prevalence and incidence rates of multiple sclerosis in Kuwait" 20 : 543-547, 2014

22 Evans C, "Incidence and prevalence of multiple sclerosis in the Americas: a systematic review" 40 : 195-210, 2013

23 Kingwell E, "Incidence and prevalence of multiple sclerosis in Europe: a systematic review" 13 : 128-, 2013

24 Kingwell E, "High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010)" 262 : 2352-2363, 2015

25 Pugliatti M, "Environmental risk factors in multiple sclerosis" 188 : 34-40, 2008

26 Ebers GC, "Environmental factors and multiple sclerosis" 7 : 268-277, 2008

27 Scalfari A, "Early relapses, onset of progression, and late outcome in multiple sclerosis" 70 : 214-222, 2013

28 Tallawy HN, "Door-to-door survey of major neurological disorders (project) in Al Quseir City, Red Sea Governorate, Egypt" 9 : 767-771, 2013

29 Polman CH, "Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria" 69 : 292-302, 2011

30 Thompson AJ, "Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria" 17 : 162-173, 2018

31 Alroughani R, "Demographics and clinical characteristics of multiple sclerosis in Kuwait" 72 : 181-185, 2014

32 Lublin FD, "Defining the clinical course of multiple sclerosis: the 2013 revisions" 83 : 278-286, 2014

33 Barkhof F, "Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis" 120 : 2059-2069, 1997

34 Miller DH, "Clinically isolated syndromes" 11 : 157-169, 2012

35 Shahwar H, "Clinical spectrum of multiple sclerosis at a tertiary care hospital in Pakistan" 24 : 221-226, 2008

36 Tanaka K, "Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988-2002" 44 : 560-566, 2005

37 Negreiros AA, "Clinical and epidemiological profile of patients diagnosed with multiple sclerosis in Joao Pessoa, Paraiba, Brazil" 73 : 741-745, 2015

38 Browne P, "Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity" 83 : 1022-1024, 2014

39 Richards RG, "A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models" 6 : 1-73, 2002